ImmuCell
ICCC
12 hedge funds and large institutions have $1.25M invested in ImmuCell in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
1% less capital invested
Capital invested by funds: $1.27M → $1.25M (-$15K)
8% less funds holding
Funds holding: 13 → 12 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$6.67K |
| 2 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$5.72K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$515 |
| 2 |
Wells Fargo
San Francisco,
California
|
-$10 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HP
1
HealthInvest Partners
Stockholm,
Sweden
| $518K | +$5.72K | +1,200 | +1% |
|
|
SRC
2
Shufro Rose & Co
New York
| $257K | – | – | – |
|
|
SKK
3
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $171K | – | – | – |
|
|
EFS
4
Essex Financial Services
Essex,
Connecticut
| $116K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $93K | +$6.67K | +1,400 | +8% |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $51K | – | – | – |
|
|
7
Morgan Stanley
New York
| $25K | -$515 | -108 | -2% |
|
8
Bank of America
Charlotte,
North Carolina
| $9K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $6K | +$6.11K | +1,282 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $4K | +$3.46K | +726 | +698% |
|
11
Creative Planning
Overland Park,
Kansas
| $2K | – | – | – |
|
|
12
Wells Fargo
San Francisco,
California
| – | -$10 | -2 | -67% |
|
ICCC Hedge Fund Activity: Q4 2014 in Review
12 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2014, worth a combined $1.25M — down 1.2% from $1.27M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ICCC positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $6.67K. The largest seller was Morgan Stanley, cutting an estimated $515.
- 12 institutional investors held ImmuCell (ICCC) as of Q4 2014, down from 13 in Q3 2014.
- Funds reported $1.25M of ImmuCell stock for Q4 2014, down 1.2% quarter-over-quarter.
- 1 fund opened new ImmuCell positions in Q4 2014 and 0 closed out, a net change of +1 holder.
- The largest ImmuCell buyer in Q4 2014 was Renaissance Technologies, an estimated $6.67K added.
- The largest ImmuCell seller in Q4 2014 was Morgan Stanley, an estimated $515 sold.
Based on aggregated 13F filings for Q4 2014.